BioPhausia is a Nordic Specialty Pharma company.
 The company provides cost-effective pharmaceuticals and focuses on three fields: generic products, niche products and original drugs.
News
2009-05-08
Interim report January – March 2009
2009-02-17
Year-end report January–December 2008

Read all press releases

Share information
BioPhausia is listed on the OMX Nordic exchange Stockholm AB, Small cap

BioPhausia at NASDAQ OMX  




Prospectus 2009
Calendar
  • Interim report January-June 2009; 28 August 2009
  • Interim report January-September 2009; 20 November 2009
  • Year End report January - December 2009, 12 February 2010